已收盤 11-06 16:00:00 美东时间
-2.960
-4.52%
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从50美元升至51美元;HC Wainwright & Co.:上调伊诺维奥制药评级至"买入",目标价5美元
11-03 18:20
华盛资讯10月30日讯,Builders FirstSource, Inc.公布2026财年Q3业绩,公司Q3营收38.54亿美元,同比下降2.2%,归母净利润0.60亿美元,同比下滑50.6%。
10-30 04:01
Builders FirstSource (NYSE:BLDR) narrows FY2026 sales outlook from $14.000 billion-$14.800 billion to $14.200 billion-$14.600 billion vs $14.305 billion estimate.
10-29 18:59
华盛资讯10月29日讯,Builders FirstSource, Inc.公布2026财年Q3业绩,公司Q3营收38.54亿美元,同比下降2.2%,归母净利润0.60亿美元,同比下滑50.6%。
10-29 18:22
Builders FirstSource (NYSE:BLDR) reported quarterly earnings of $1.51 per share which beat the analyst consensus estimate of $1.04 by 45.19 percent. This is a 19.68 percent decrease over earnings of $1.88 per share from the same period last year. The company reported quarterly sales of $3.854 billio...
10-29 18:07
今日重点评级关注:Stifel:维持ORIC Pharmaceuticals"买入"评级,目标价从14美元升至18美元;花旗:维持Liberty Energy"买入"评级,目标价从27.5美元升至28美元
10-27 12:30
Stifel analyst W. Andrew Carter maintains Builders FirstSource (NYSE:BLDR) with a Hold and lowers the price target from $65 to $55.
10-26 23:48
William Blair analyst Ryan Merkel downgrades Builders FirstSource (NYSE:BLDR) from Outperform to Market Perform.
10-23 03:30
今日重点评级关注:Leerink Partners:维持First Tracks"跑赢大市"评级,目标价从70美元升至90美元;Keybanc:维持Absci"超配"评级,目标价从16美元升至20美元
10-19 18:42
Wells Fargo analyst Sam Reid maintains Builders FirstSource (NYSE:BLDR) with a Equal-Weight and lowers the price target from $63 to $55.
10-17 00:13